169 related articles for article (PubMed ID: 35947016)
101. Clinical Significance of Serum Type III Interferons in Patients with Gastric Cancer.
Zhao H; Dong N; Liu T; Zhang P; Zheng Y; Yang L; Ren X
J Interferon Cytokine Res; 2019 Mar; 39(3):155-163. PubMed ID: 30672717
[TBL] [Abstract][Full Text] [Related]
102. Plasma metabolome identifies potential biomarkers of gastric precancerous lesions and gastric cancer risk.
Li B; Shu X; Jiang H; Shi C; Qi L; Zhu L; Zhou J; Tang M; Hu A
Metabolomics; 2023 Aug; 19(8):73. PubMed ID: 37561286
[TBL] [Abstract][Full Text] [Related]
103. Presence of blood in gastric juice: A sensitive marker for gastric cancer screening in a poor resource setting.
Kayamba V; Zyambo K; Kelly P
PLoS One; 2018; 13(10):e0205185. PubMed ID: 30321216
[TBL] [Abstract][Full Text] [Related]
104. Ribosomal DNA copy number alteration in blood sample from gastric cancer patients.
Chen C; Feng L; Chen J; Shen J; Lin L
Mol Biol Rep; 2023 Sep; 50(9):7155-7160. PubMed ID: 37407803
[TBL] [Abstract][Full Text] [Related]
105. Gastric juice non-coding RNAs as potential biomarkers for gastric cancer.
Gareev I; Ahmad A; Wang J; Beilerli A; Ilyasova T; Sufianov A; Beylerli O
Front Physiol; 2023; 14():1179582. PubMed ID: 37179825
[TBL] [Abstract][Full Text] [Related]
106. Correlation of Serum CA242, CA724, and TPA Levels with Clinicopathological Features and Prognosis in Patients with Inflammatory Bowel Disease Complicated with Rectal Cancer.
Liang H; Yang X
J Oncol; 2022; 2022():7742760. PubMed ID: 36245974
[TBL] [Abstract][Full Text] [Related]
107. Urine proteomic signatures predicting the progression from premalignancy to malignant gastric cancer.
Fan H; Li X; Li ZW; Zheng NR; Cao LH; Liu ZC; Liu MW; Li K; Wu WH; Li ZX; Zhou T; Zhang Y; Liu WD; Zhang LF; You WC; Wang Y; Wu J; Pan KF; Qin J; Li WQ
EBioMedicine; 2022 Dec; 86():104340. PubMed ID: 36356476
[TBL] [Abstract][Full Text] [Related]
108. Clinical Value on Combined Detection of Serum CA724, DKK1, and TK1 in Diagnosis of Gastric Cancer.
Wang Y; Cui D; Li D; Li D; Wang H; Wu Y
J Oncol; 2022; 2022():6941748. PubMed ID: 36276284
[TBL] [Abstract][Full Text] [Related]
109. Gastric cancer detection by non-blood-based liquid biopsies: A systematic review looking into the last decade of research.
Lopes C; Chaves J; Ortigão R; Dinis-Ribeiro M; Pereira C
United European Gastroenterol J; 2023 Feb; 11(1):114-130. PubMed ID: 36461757
[TBL] [Abstract][Full Text] [Related]
110. Screening of novel serum biomarkers for gastric cancer in coastal populations using a protein microarray.
Yi Y; Nan R; Lu J; Liang D; Zhao S; Wang X; Zhang H; Chen B; Chen J; Zheng Z; You T; Chen T; Chen X; Wang W; Lin L; Chen Y; Liu S; Huang Y; Yu Y; Lu M; Li P; Huang H; Zhou G; Lin X; Wu H; Shen X; Sun W
Cancer Sci; 2023 Aug; 114(8):3396-3410. PubMed ID: 37290894
[TBL] [Abstract][Full Text] [Related]
111. A New Method for Early Screening of Gastric Cancer (G17 and CA724 Dual-Labeled Time-Resolved Fluorescence Immunoassay).
Liu C; Chen C; Lai H; Liang H; Zhong S; Guo G; Wang L; Li L
Comput Math Methods Med; 2022; 2022():1704948. PubMed ID: 35912162
[TBL] [Abstract][Full Text] [Related]
112. Comprehensive Evaluation of Serum tRF-17-WS7K092 as a Promising Biomarker for the Diagnosis of Gastric Cancer.
Gu X; Zhang Y; Huang Y; Ju S
J Oncol; 2022; 2022():8438726. PubMed ID: 36245992
[TBL] [Abstract][Full Text] [Related]
113. Identification of stromal cell-derived factor 4 as a liquid biopsy-based diagnostic marker in solid cancers.
Shinozuka T; Kanda M; Shimizu D; Umeda S; Takami H; Inokawa Y; Hattori N; Hayashi M; Tanaka C; Nakayama G; Kodera Y
Sci Rep; 2023 Sep; 13(1):15540. PubMed ID: 37730904
[TBL] [Abstract][Full Text] [Related]
114. Implementation of gastric cancer screening - the global experience.
Leja M; You W; Camargo MC; Saito H
Best Pract Res Clin Gastroenterol; 2014 Dec; 28(6):1093-106. PubMed ID: 25439074
[TBL] [Abstract][Full Text] [Related]
115. Development and validation of an artificial neural network model for non-invasive gastric cancer screening and diagnosis.
Fan Z; Guo Y; Gu X; Huang R; Miao W
Sci Rep; 2022 Dec; 12(1):21795. PubMed ID: 36526664
[TBL] [Abstract][Full Text] [Related]
116. Site-specific protein biomarkers in gastric cancer: a comprehensive review of novel biomarkers and clinical applications.
Shinozuka T; Kanda M; Kodera Y
Expert Rev Mol Diagn; 2023; 23(8):701-712. PubMed ID: 37395000
[TBL] [Abstract][Full Text] [Related]
117. Alterations in bacterial community dynamics from noncancerous to Gastric cancer.
Peng X; Yao S; Huang J; Zhao Y; Chen H; Chen L; Yu Z
Front Microbiol; 2023; 14():1138928. PubMed ID: 36970687
[TBL] [Abstract][Full Text] [Related]
118. SERPINB5 is a novel serum diagnostic biomarker for gastric high-grade intraepithelial neoplasia and plays a role in regulation of macrophage phenotypes.
Huang X; Xie X; Kang N; Qi R; Zhou X; Wang Y; Jiang H
Transl Oncol; 2023 Nov; 37():101757. PubMed ID: 37573714
[TBL] [Abstract][Full Text] [Related]
119. Significance of Serum Apelin Levels as a Biomarker for Gastric Cancer Diagnosis.
Hedayatizadeh-Omran A; Shekarriz R; Amjadi O; Alizadeh-Navaei R; Babamohammadi S
Asian Pac J Cancer Prev; 2023 Mar; 24(3):827-831. PubMed ID: 36974534
[TBL] [Abstract][Full Text] [Related]
120. Determination of serum CA724 levels using fluorescence immunochromatography.
Liu C; Chen C; Peng F; Liang H; Zhong S; Liu T; Li L; Boronin A; Dong W
BMC Biotechnol; 2023 Aug; 23(1):30. PubMed ID: 37596558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
